Top Story

PFO closure resolves postural dyspnea, hypoxemia in platypnea-orthodeoxia syndrome

October 8, 2015

Closure of a patent foramen ovale resolved symptoms of postural dyspnea and hypoxemia and was effective for treating platypnea-orthodeoxia syndrome, except for situations in which hypoxemia is related to a pulmonary origin, according to recent findings in Catheterization and Cardiovascular Interventions.

“In patients with platypnea-orthodeoxia [syndrome] who have a large intracardiac [right to left] shunt, successful closure of the PFO may resolve symptomatic postural dyspnea and profound hypoxemia,” the researchers wrote.

Donna Arnett, PhD In the Journals

New-onset diabetes risk rises with BP

October 8, 2015
Elevated BP may be a risk factor for new-onset type 2 diabetes, and the association appears strongest in those who are younger and have a lower BMI, according to an…
Qibin Qi, PhD In the Journals

Sedentary behaviors may increase CVD risk in Hispanics

October 8, 2015
Increased sedentary time and behaviors may increase risk for CVD in U.S. Hispanic adults, according to study results published in Circulation.“Prolonged sedentary…
In the Journals

Institutional volume influences catheter-directed thrombolysis outcomes

October 8, 2015
An increase in institutional volume of catheter-directed thrombolysis led to reductions in rates of in-hospital mortality and intracranial hemorrhage in patients with…
Kenneth Freedland In the Journals

CBT effective in treating depression in heart failure patients

October 8, 2015
A cognitive behavior therapy intervention that targeted heart failure self-care and depression was effective in treating depression, according to data published in JAMA
More News Headlines »
Cardiology Case Consults

The Patient With Severe Hypertriglyceridemia

No commercial support for this activity.

Elevated serum triglycerides are a highly prevalent yet modifiable risk factor for atherosclerotic disease and its…
More »
Meeting News Coverage Video
VIDEO: Expert discusses future of hyperkalemia management in patients with HF

VIDEO: Expert discusses future of hyperkalemia management in patients with HF

September 28, 2015
NATIONAL HARBOR, Md. — In this video, Javed Butler, MD, chief of cardiology and co-director of the Heart…
More »
J832 Activity Image 3

Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients with History of Cerebrovascular Disease

This activity is supported by an educational grant from Merck & Co., Inc.

In this CME activity, Dr. David Morrow discusses the use of antiplatelet agents for secondary prevention of thrombotic…
More »